Budget Impact Analysis of Biosimilar Trastuzumab for the Treatment of Breast Cancer in Croatia.
August CesarecRobert LikićPublished in: Applied health economics and health policy (2017)
The introduction of biosimilar trastuzumab could lead to significant drug cost savings in Croatia.